Currently, there are 154.59M common shares owned by the public and among those 149.77M shares have been available to trade.
The company’s stock has a 5-day price change of -29.40% and 25.37% over the past three months. AKTS shares are trading -91.82% year to date (YTD), with the 12-month market performance down to -89.09% lower. It has a 12-month low price of $0.04 and touched a high of $1.19 over the same period. AKTS has an average intraday trading volume of 20.95 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -24.01%, -7.27%, and -70.07% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Akoustis Technologies Inc (NASDAQ: AKTS) shares accounts for 13.68% of the company’s 154.59M shares outstanding.
It has a market capitalization of $9.43M and a beta (3y monthly) value of 1.92. The earnings-per-share (ttm) stands at -$1.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.45% over the week and 25.77% over the month.
Looking at the support for the AKTS, a number of firms have released research notes about the stock. Piper Sandler stated their Neutral rating for the stock in a research note on January 04, 2024, with the firm’s price target at $2-$1. B. Riley Securities coverage for the Akoustis Technologies Inc (AKTS) stock in a research note released on September 06, 2023 offered a Neutral rating with a price target of $1.75. B. Riley Securities was of a view on January 24, 2023 that the stock is Buy, while Craig Hallum gave the stock Buy rating on February 02, 2021, issuing a price target of $18- $20. Craig Hallum on their part issued Buy rating on January 15, 2021.
